Literature DB >> 20578711

Solution phase synthesis of a combinatorial library of chalcones and flavones as potent cathepsin V inhibitors.

Joel Alvim1, Richele P Severino, Emerson F Marques, Ariane M Martinelli, Paulo C Vieira, João B Fernandes, M Fatima das G F da Silva, Arlene G Corrêa.   

Abstract

Cathepsin V is a papain-like cysteine protease. It is involved in the control of human T cells (responsible for cell immunity), and presents the largest elastolytic activity among the proteolytic enzymes. Therefore, cathepsin V is a potential molecular target for the treatment of atherosclerosis. In the present work, natural flavonoids were screened against cathepsin V, and two flavones were identified as potent inhibitors of cathepsin V. On the basis of this result, a combinatorial library of chalcones and flavones was prepared, in solution phase employing a scavenger reagent, and fully evaluated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578711     DOI: 10.1021/cc100076k

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  2 in total

1.  New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.

Authors:  Ana Mitrović; Emanuela Senjor; Marko Jukić; Lara Bolčina; Mateja Prunk; Matic Proj; Milica Perišić Nanut; Stanislav Gobec; Janko Kos
Journal:  Comput Struct Biotechnol J       Date:  2022-08-28       Impact factor: 6.155

2.  By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.

Authors:  Kamel Deramchia; Marie-Josee Jacobin-Valat; Jeanny Laroche-Traineau; Stephane Bonetto; Stephane Sanchez; Pierre Dos Santos; Philippe Massot; Jean-Michel Franconi; Pierre Martineau; Gisele Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.